Literature DB >> 12714696

Mitochondrial impairment in p53-deficient human cancer cells.

Shaoyu Zhou1, Sushant Kachhap, Keshav K Singh.   

Abstract

The mechanism linking p53 inactivation to human cell malignancy remains unclear. Studies have indicated that mitochondrial dysfunction is involved in carcinogenesis. In this study we investigated the role of p53 in mitochondrial DNA (mtDNA) mutation and maintenance of proper mitochondrial function. We measured mtDNA mutation and found no difference in frequency of mutation between the p53(+/+) and p53(-/-) cell lines. However, mitochondrial cytochrome c oxidase (COX) activity was significantly diminished in p53(-/-) cells. This decrease in COX activity was attributed to decreased protein levels of the COXII subunit encoded by the mitochondrial genome and was not due to mutation in the mitochondrial COXII gene. Further investigation revealed no concomitant decrease in COXII mRNA levels in p53(-/-) cells and the stability of mRNA in p53(-/-) cells was unaffected. This study suggests that decreased COX activity is likely due to post-transcriptional regulation of the COXII subunit by p53. COX is a critical enzyme in the mitochondrial electron transport chain and reduced COX activity may affect mitochondrial structure. However, examination of mitochondrial ultrastructure revealed no obvious differences between p53(+/+) and p53(-/-) cell lines. Together, our study suggests that p53 is involved in regulation of COXII at the protein level but not at the mRNA level. p53 does not affect mtDNA mutation or mitochondrial ultrastructure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12714696     DOI: 10.1093/mutage/18.3.287

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  46 in total

Review 1.  p53 regulation of metabolic pathways.

Authors:  Eyal Gottlieb; Karen H Vousden
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-02       Impact factor: 10.005

Review 2.  Genetic insights into OXPHOS defect and its role in cancer.

Authors:  Dhyan Chandra; Keshav K Singh
Journal:  Biochim Biophys Acta       Date:  2010-11-11

Review 3.  Tumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication.

Authors:  Nadi T Wickramasekera; Gokul M Das
Journal:  Mitochondrion       Date:  2013-10-29       Impact factor: 4.160

4.  p53 Protects lung cancer cells against metabolic stress.

Authors:  Chompunoot Sinthupibulyakit; Wanida Ittarat; William H St Clair; Daret K St Clair
Journal:  Int J Oncol       Date:  2010-12       Impact factor: 5.650

Review 5.  Defining the momiome: Promiscuous information transfer by mobile mitochondria and the mitochondrial genome.

Authors:  Bhupendra Singh; Josephine S Modica-Napolitano; Keshav K Singh
Journal:  Semin Cancer Biol       Date:  2017-05-11       Impact factor: 15.707

6.  Investigation of the association between mitochondrial DNA and p53 gene mutations in transitional cell carcinoma of the bladder.

Authors:  Tuba Avcilar; Deniz Kirac; Deniz Ergec; Gulsah Koc; Korkut Ulucan; Zehra Kaya; Elif Cigdem Kaspar; Levent Turkeri; Ahmet Ilter Guney
Journal:  Oncol Lett       Date:  2016-08-11       Impact factor: 2.967

7.  Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2013-09-10       Impact factor: 3.584

8.  Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review).

Authors:  Jie Zheng
Journal:  Oncol Lett       Date:  2012-09-20       Impact factor: 2.967

9.  Expression and maintenance of mitochondrial DNA: new insights into human disease pathology.

Authors:  Gerald S Shadel
Journal:  Am J Pathol       Date:  2008-05-05       Impact factor: 4.307

Review 10.  Metabolic regulation of oxygen and redox homeostasis by p53: lessons from evolutionary biology?

Authors:  Jie Zhuang; Wenzhe Ma; Cory U Lago; Paul M Hwang
Journal:  Free Radic Biol Med       Date:  2012-07-25       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.